US ACV is $7m pa (as at 30/6/17) and guidance is for that to double in FY 2018. It wouldn't surprise me if they greatly exceeded that now that they are "established" in the US.
But, time will tell.
Obviously, its very disappointing to see the SP at current levels. Its anyones guess as to whether it goes up down or sideways short term but longer term, I'm optimistic and we could get dramatically increased sales numbers for the US at any time.
- Forums
- ASX - By Stock
- NEA
- Ann: 2017 AGM Presentation
Ann: 2017 AGM Presentation, page-31
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online